secwatch.observer — SEC 8-K summary
======================================

Issuer:     Covista Inc. (CVSA)
CIK:        0000730464
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001157523-22-001521
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adtalem Q1 revenue $354.6M (+22.7%); adjusted EPS $0.88 (+151%); margins expand
-------------------------------------------------------------------------------

- Revenue $354.6M up 22.7% YoY; diluted EPS $0.05 vs loss of $1.17; adjusted EPS $0.88 up 151.4%.
- Adjusted operating income $65.1M up 78.7%; adjusted EBITDA $82.1M up 62.6%; margin expanded to 23.1% from 17.5%.
- Gross debt reduced by $101M (11.7%) in Q1.
- Segment: Chamberlain revenue flat, enrollment -4%; Walden enrollment -9.2%; Medical/Vet enrollment +3.4%.
- Reaffirmed FY2023 guidance: revenue $1,380M-$1,450M, adjusted EPS $3.95-$4.20.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730464/000115752322001521/0001157523-22-001521-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730464/000115752322001521/a52959534.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-001521

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer